Neogen (NEOG)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$11.83+1.63%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · NEOG
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 870.4 | 870.4 | 894.7 | 924.2 | 822.4 | 527.2 | 468.5 | 418.2 | 414.2 | 397.9 | 361.6 | 321.3 | 283.1 | 247.4 | 207.5 | 184.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | 361.6 | 321.3 | 283.1 | 247.4 | 207.5 | 184.0 |
| Cost of Revenues | 461.9 | 461.9 | 473.3 | 460.3 | 416.5 | 284.1 | 253.4 | 221.9 | 222.3 | 211.7 | 189.6 | 168.2 | 143.4 | 124.8 | 98.0 | — |
| Gross Profit | 408.5 | 408.5 | 421.4 | 463.9 | 406.0 | 243.0 | 215.1 | 196.3 | 191.9 | 186.3 | 168.9 | 153.1 | 139.7 | 122.6 | 109.5 | 92.4 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 18.4 | 18.4 | 21.1 | 22.5 | 26.0 | 17.0 | 16.2 | 14.8 | 12.8 | 10.9 | 10.4 | 9.9 | 9.6 | 8.3 | 7.8 | 6.6 |
| Operating Income | (21.6) | (21.6) | (1,061.0) | 58.7 | 37.5 | 58.6 | 74.2 | 67.5 | 68.1 | 70.2 | 64.9 | 56.4 | 53.1 | 43.4 | 40.7 | 33.7 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 24.1 | 38.1 | 42.2 | 27.3 | — | — | — | — | — | — | — | — | — | — | — |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | 0.8 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 |
| Other Non-Operating Income / Expenses | 12.6 | 12.6 | (72.1) | (73.0) | (59.6) | 1.6 | 1.1 | 4.8 | 4.9 | 3.3 | 1.7 | (0.9) | (1.0) | (0.4) | 0.4 | 0.1 |
| EBT, Incl. Unusual Items | (9.0) | (9.0) | (1,133.1) | (14.3) | (22.0) | 60.2 | 75.3 | 72.3 | 73.0 | 73.5 | 66.7 | 55.5 | 52.1 | 43.0 | 41.1 | 33.8 |
| Income Tax Expense | (1.1) | (1.1) | (41.1) | (4.9) | 0.8 | 11.9 | 14.4 | 12.8 | 12.8 | 10.3 | 22.7 | 19.0 | 18.5 | 15.0 | 14.1 | 11.5 |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | — | — | — | — | 0.0 | 0.1 | 0.2 | (0.0) | 0.1 | (0.1) | (0.1) | — |
| Net Income | (7.9) | (7.9) | (1,092.0) | (9.4) | (22.9) | 48.3 | 60.9 | 59.5 | 60.2 | 63.1 | 43.8 | 36.6 | 33.5 | 28.2 | 27.2 | 22.5 |
| Per Share | ||||||||||||||||
| Basic EPS | — | (0.04) | (5.03) | (0.04) | (0.12) | 0.45 | 0.57 | 0.57 | 0.58 | 1.23 | 0.87 | 0.73 | 0.91 | 0.77 | 0.76 | 0.64 |
| Diluted EPS | — | (0.04) | (5.03) | (0.04) | (0.12) | 0.45 | 0.57 | 0.56 | 0.57 | 1.21 | 0.86 | 0.72 | 0.90 | 0.76 | 0.75 | 0.62 |
| Basic Weighted Avg Shares | — | 217.5 | 216.9 | 216.5 | 188.9 | 107.7 | 106.5 | 105.1 | 103.8 | 51.4 | 50.5 | 49.9 | 37.0 | 36.5 | 35.8 | 35.2 |
| Diluted Weighted Avg Shares | — | 217.5 | 216.9 | 216.5 | 188.9 | 108.0 | 107.1 | 105.7 | 104.9 | 52.1 | 51.2 | 50.5 | 37.4 | 37.3 | 36.5 | 36.0 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 94.7 | (941.5) | 175.4 | 125.9 | 82.3 | 95.2 | 85.9 | 85.7 | 87.3 | 79.6 | 68.6 | 63.8 | 52.6 | 48.1 | 39.9 |
| EBIT | (21.6) | (21.6) | (1,061.0) | 58.7 | 37.5 | 58.6 | 74.2 | 67.5 | 68.1 | 70.2 | 64.9 | 56.4 | 53.1 | 43.4 | 40.7 | 33.7 |
| Effective Tax Rate | 12.2% | — | — | — | -3.8% | 19.8% | 19.1% | 17.7% | 17.5% | 14.0% | 34.0% | 34.2% | 35.5% | 34.9% | 34.3% | 33.8% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.